CPAP Machine Market Summary
According to the new market research report “Global CPAP Machine Market Report 2023-2029”, published by QYResearch, the global CPAP Machine market size is projected to reach USD 4.54 billion by 2029, at a CAGR of 8.6% during the forecast period.
According to QYResearch Top Players Research Center, the global key manufacturers of CPAP Machine include ResMed, Fisher & Paykel Healthcare, BMC Medical, Philips, Weinmann Emergency Medical, Breas Medical, SLS Medical Technology, Nidek Medical India, Wellell, Hunan Beyond Medical, etc. In 2022, the global top five players had a share approximately 72.0% in terms of revenue.
In terms of product type, currently CPAP is the largest segment, hold a share of 49.2%.
In terms of product application, currently Home Care is the largest segment, hold a share of 56.1%.
Market Drivers:
CPAP typically is used for people who have breathing problems, such as sleep apnea. CPAP also may be used to treat preterm infants whose lungs have not yet fully developed. For example, physicians may use CPAP in infants with respiratory distress syndrome. It is associated with a decrease in the incidence of bronchopulmonary dysplasia. In some preterm infants whose lungs have not fully developed, CPAP improves survival and decreases the need for steroid treatment for their lungs. In resource-limited settings where CPAP improves respiratory rate and survival in children with primary pulmonary disease, researchers have found that nurses can initiate and manage care with once or twice daily physician rounds.
CPAP therapy utilizes machines specifically designed to deliver a constant flow of pressure. Some CPAP machines have other features as well, such as heated humidifiers. CPAP is the most effective treatment for obstructive sleep apnea, in which the mild pressure from the CPAP prevents the airway from collapsing or becoming blocked.
The global sleep apnea devices market is expected to witness substantial growth owing to high prevalence of Obstructive Sleep Apnea (OSA) patients. Downsides of urban lifestyle such as long working hours, obesity, diabetes, and anxiety have resulted in increased sleep disorders, consequently driving sleep apnea devices demand. Leading market players have invested heavily in the development of compact therapeutic devices, which is expected to favorably impact sleep apnea devices market growth.
Restraint:
Unlike CPAP, combined surgery and DISE pose a promising and potentially curative approach to treating adult OSA, therefore warranting greater attention and consequently further research efforts focusing on surgical outcomes.
Oral appliances (eg, mandibular advancement devices, tongue retaining devices) are an alternative therapeutic strategy in OSA that may be offered to patients with mild to moderate OSA who decline or fail to adhere to positive airway pressure therapy and who have a preference for such treatment.
Oral appliances — For patients with mild or moderate OSA who decline or fail to adhere to positive airway pressure therapy, an oral appliance is a reasonable alternative to positive airway pressure. This is based upon the recognition that while positive airway pressure is generally more effective than an oral appliance at normalizing respiratory events and oxyhemoglobin desaturation episodes during sleep, most patients prefer an oral appliance, adherence is an essential aspect of successful treatment, both modalities are effective compared to no treatment or a sham treatment, and both modalities have a similar effect on symptoms and quality of life.
Upper airway surgery — There is no consensus regarding the role of surgery in patients with OSA of varying degrees of severity, nor have optimal screening or imaging procedures been established that accurately predict which patients are most likely to benefit from surgery. We generally consider surgical therapy when positive airway pressure or an oral appliance is declined or ineffective (after at least a three month trial of therapy). Surgical treatment appears to be most effective in patients who have OSA due to a severe, surgically correctable, obstructing lesion of the upper airway. Examples of surgically correctable lesions that may obstruct the upper airway include tonsillar hypertrophy, adenoid hypertrophy, or craniofacial abnormalities.
Hypoglossal nerve stimulation via an implantable neurostimulator device is a treatment strategy that may have a role in selected patients with moderate to severe OSA, who have failed continuous positive airway pressure with a body mass index <32 kg/m2, and no funfavorable collapse on drug-induced sleep endoscopy. Uncontrolled studies and a meta-analysis of such studies have shown significant reductions in AHI and oxygen saturation index as well as improvement in subjective measures of sleepiness after device implantation in selected patients.
About The Authors
Zhang Xiong - Lead Author
Email: zhangxiong@qyresearch.com
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.